➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
McKesson
Dow
Boehringer Ingelheim
Mallinckrodt

Last Updated: May 16, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: LAMIVUDINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

LAMIVUDINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Viiv Hlthcare EPIVIR lamivudine SOLUTION;ORAL 020596 NDA ViiV Healthcare Company 49702-205-48 240 mL in 1 BOTTLE (49702-205-48) 2010-10-04
Glaxosmithkline EPIVIR-HBV lamivudine SOLUTION;ORAL 021004 NDA GlaxoSmithKline LLC 0173-0663-00 240 mL in 1 BOTTLE (0173-0663-00) 1998-12-23
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695 ANDA Rising Health, LLC 57237-274-24 240 mL in 1 BOTTLE (57237-274-24) 2016-11-21
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Moodys
Dow
Baxter
Johnson and Johnson